DEA Places Synthetic Drug in Schedule I
The Drug Enforcement Administration permanently placed 2-methyl AP-237, a synthetic drug that acts like an opioid, in Schedule I of the Controlled Substances Act, in a final rule released March 14. New registration, labeling, record-keeping, and import and export requirements…
Sign up for a free preview to unlock the rest of this article
Export Compliance Daily combines U.S. export control news, foreign border import regulation and policy developments into a single daily information service that reliably informs its trade professional readers about important current issues affecting their operations.
under the final rule take effect April 15.